ArticleNeurology and therapy2026
Safety and Effectiveness of Inebilizumab in Patients with Neuromyelitis Optica Spectrum Disorder: Interim Analysis of a Post-marketing Surveillance in Japan.
Kazuo Fujihara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.